-40%
120,70 €
Statt 199,99 €**
120,70 €
inkl. MwSt.
**Preis der gedruckten Ausgabe (Gebundenes Buch)
Sofort per Download lieferbar
Statt 199,99 €**
120,70 €
inkl. MwSt.
**Preis der gedruckten Ausgabe (Gebundenes Buch)
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
Als Download kaufen
Statt 199,99 €**
-40%
120,70 €
inkl. MwSt.
**Preis der gedruckten Ausgabe (Gebundenes Buch)
Sofort per Download lieferbar
Abo Download
9,90 € / Monat*
*Abopreis beinhaltet vier eBooks, die aus der tolino select Titelauswahl im Abo geladen werden können.

inkl. MwSt.
Sofort per Download lieferbar

Einmalig pro Kunde einen Monat kostenlos testen (danach 9,90 € pro Monat), jeden Monat 4 aus 40 Titeln wählen, monatlich kündbar.

Mehr zum tolino select eBook-Abo
Jetzt verschenken
Statt 199,99 €**
-40%
120,70 €
inkl. MwSt.
**Preis der gedruckten Ausgabe (Gebundenes Buch)
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
60 °P sammeln

  • Format: PDF


Erythropoietin (EPO) is a chemokine hormone that is widely distributed throughout the body. In addition to its traditional role as a hormone that stimulates red blood cell production, in recent years many laboratories have shown that EPO can act as a neuroprotective compound in a variety of injury paradigms in the nervous system. Past experience with relatively safety profile of this FDA-approved drug makes it an ideal candidate to take it into clinical trials for neuroprotection. We are on the verge of major clinical trials using this drug for neuroprotection in diseases ranging from stroke,…mehr

  • Geräte: PC
  • ohne Kopierschutz
  • eBook Hilfe
  • Größe: 13.22MB
Produktbeschreibung
Erythropoietin (EPO) is a chemokine hormone that is widely distributed throughout the body. In addition to its traditional role as a hormone that stimulates red blood cell production, in recent years many laboratories have shown that EPO can act as a neuroprotective compound in a variety of injury paradigms in the nervous system. Past experience with relatively safety profile of this FDA-approved drug makes it an ideal candidate to take it into clinical trials for neuroprotection. We are on the verge of major clinical trials using this drug for neuroprotection in diseases ranging from stroke, to transverse myelitis to chemotherapy-induced peripheral neuropathy. This is the first book of its kind that brings together researchers from many different disciplines of neuroscience to review the current state-of-the-art in EPO and the nervous system. This book will benefit scientists and clinicians interested in neuroprotection in the broadest sense. TOC:History and biology of erythropoietin in hematopoietic system and tissues other than nervous system.- Expression of erythropoietin and its receptor in the central nervous system.- Erythropoietin and neuroprotection in the Central Nervous System.- Regulation of Erythropoietin expression in the nervous system.- Erythropoietin in the developing brain.- Erythropoietin for the treatment of Acute Ischemic Stroke.- Erythropoietin protects retinal ganglion cells against ischemia and axotomy-induced neuronal death.- Erythropoietin for treatment of human brain disease.- Erythropoietin and the Spinal Cord Injury.- Erythropoietin and neuroprotection in the Peripheral Nervous System.- An endogenous neuroprotective pathway in the peripheral nervous system mediated by Schwann cell - derived erythropoietin.- Role of erythropoietin in inflammatory pathologies of the CNS.- Development of non-erythropoietic erythropoietin variants for neuroprotection.

Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

  • Produktdetails
  • Verlag: Springer-Verlag GmbH
  • Erscheinungstermin: 28.09.2006
  • Englisch
  • ISBN-13: 9780387300115
  • Artikelnr.: 37285197
Autorenporträt
Ahmet Hoke, Johns Hopkins Hospital, Baltimore, MD, USA
Inhaltsangabe
History and Biology of Erythropoietin in Hematopoietic and Non-Neural Tissues.- Expression of Erythropoietin and Its Receptor in the Central Nervous System.- Erythropoietin and Neuroprotection in the Central Nervous System: Intracellular Signaling Pathways.- Regulation of Erythropoietin Expression in the Nervous System: The Hypoxia Inducible Factor.- Erythropoietin Neuroprotection in the Term and Preterm Infant: Safety and Efficacy.- Erythropoietin for the Treatment of Acute Ischemic Stroke: Preclinical Rationale.- Erythropoietin Neuroprotection in the Retina.- Erythropoietin for Treatment of Human Brain Disease: Experience from Proof-of-Concept Trials.- Erythropoietin in Spinal Cord Injury.- Erythropoietin and Neuroprotection in the Peripheral Nervous System: In Vivo Studies.- An Endogenous Pathway Preventing Axonal Degeneration Mediated by Schwann Cell - Derived Erythropoietin.- Role of Erythropoietin in Inflammatory Pathologies of the CNS.- Development of Non-Erythropoietic Erythropoietin Variants for Neuroprotection.